The Ketamine Research Foundation (KRF), led by Dr. Phil Wolfson, has published a guide of interest to the entire community. Once again, the KRF reinstates its leadership in the field of mental health, psychological wellbeing and ketamine-assisted therapy. Phil Wolfson, a pioneer of Ketamine Assisted Psychotherapy (KAP) and early and
We explore the use of psychedelic therapy in the treatment of grief
Psilocybin and Depression Depression affects approximately 280 million people worldwide, making it a significant public health issue (1). Symptoms described in the Diagnostic and Statistical Manual of Mental Disorders include sadness, sleep disturbances, changes in appetite and energy levels, suicidal ideation, anhedonia, and diminished interest (2). A combination of both
How important is music in the sessions? We discuss it in this post
We talk about fear and trauma, discussing the possible use of MDMA for the treatment of PTSD
In this post we talk about chronic pain and the possibility of treatment with ketamine-assisted therapy
Can ketamine work where classic antidepressants have not worked?
The information on this website is intended for healthcare professionals authorized to prescribe or dispense medications who practice their profession in Spain. Therefore, specialized training is required to interpret it correctly. The mentioned product may have a different authorized data sheet in other countries. By clicking the “Accept” button, you confirm that you are a healthcare professional authorized to prescribe or dispense medications and that you wish to access the information on this website in that capacity.